It was found that the combination therapy or monoclonal antibody alone can slow down tumor growth, the combination therapy did not significantly improve the efficacy, and the tumor grafts increased IFNγ-secreting human T cells and decreased human Treg cells. The gene discussed is IFNG; the disease is neoplasm.